Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Snowden
H
H
Woolridge
M
M
Renfrew
M
M
D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D005687:Galactorrhea / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D008787:Metoclopramide / Q000009:adverse effects / Q000627:therapeutic use; D010902:Pituitary Gland / Q000187:drug effects
D017320:HIV Protease Inhibitors; D005473:Fluoxetine; D008787:Metoclopramide